Literature DB >> 24710030

Inhibition of glycosphingolipid synthesis ameliorates atherosclerosis and arterial stiffness in apolipoprotein E-/- mice and rabbits fed a high-fat and -cholesterol diet.

Subroto Chatterjee1, Djahida Bedja2, Sumita Mishra2, Christine Amuzie2, Alberto Avolio2, David A Kass2, Dan Berkowitz2, Mark Renehan2.   

Abstract

BACKGROUND: Glycosphingolipids, integral components of the cell membrane, have been shown to serve as messengers, transducing growth factor-initiated phenotypes. Here, we have examined whether inhibition of glycosphingolipid synthesis could ameliorate atherosclerosis and arterial stiffness in transgenic mice and rabbits. METHODS AND
RESULTS: Apolipoprotein E(-/-) mice (12 weeks of age; n=6) were fed regular chow or a Western diet (1.25% cholesterol, 2% fat). Mice were fed 5 or 10 mg/kg of an inhibitor of glycosphingolipid synthesis, D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (D-PDMP), solubilized in vehicle (5% Tween-80 in PBS); the placebo group received vehicle only. At 20 and 36 weeks of age, serial echocardiography was performed to measure aortic intima-media thickening. Aortic pulse-wave velocity measured vascular stiffness. Feeding mice a Western diet markedly increased aortic pulse-wave velocity, intima-media thickening, oxidized low-density lipoprotein, Ca(2+) deposits, and glucosylceramide and lactosylceramide synthase activity. These were dose-dependently decreased by feeding D-PDMP. In liver, D-PDMP decreased cholesterol and triglyceride levels by raising the expression of SREBP2, low-density lipoprotein receptor, HMGCo-A reductase, and the cholesterol efflux genes (eg, ABCG5, ABCG8). D-PDMP affected very-low-density lipoprotein catabolism by increasing the gene expression for lipoprotein lipase and very-low-density lipoprotein receptor. Rabbits fed a Western diet for 90 days had extensive atherosclerosis accompanied by a 17.5-fold increase in total cholesterol levels and a 3-fold increase in lactosylceramide levels. This was completely prevented by feeding D-PDMP.
CONCLUSIONS: Inhibition of glycosphingolipid synthesis ameliorates atherosclerosis and arterial stiffness in apolipoprotein E(-/-) mice and rabbits. Thus, inhibition of glycosphingolipid synthesis may be a novel approach to ameliorate atherosclerosis and arterial stiffness.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  atherosclerosis; glycosphingolipids; mice, knockout; molecular imaging

Mesh:

Substances:

Year:  2014        PMID: 24710030      PMCID: PMC4053506          DOI: 10.1161/CIRCULATIONAHA.113.007559

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  26 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  Oxidized low density lipoprotein stimulates aortic smooth muscle cell proliferation.

Authors:  S Chatterjee; N Ghosh
Journal:  Glycobiology       Date:  1996-04       Impact factor: 4.313

3.  Glycosphingolipid accumulation inhibits cholesterol efflux via the ABCA1/apolipoprotein A-I pathway: 1-phenyl-2-decanoylamino-3-morpholino-1-propanol is a novel cholesterol efflux accelerator.

Authors:  Elias N Glaros; Woojin Scott Kim; Carmel M Quinn; Jenny Wong; Ingrid Gelissen; Wendy Jessup; Brett Garner
Journal:  J Biol Chem       Date:  2005-05-11       Impact factor: 5.157

4.  Lactosylceramide mediates tumor necrosis factor-alpha-induced intercellular adhesion molecule-1 (ICAM-1) expression and the adhesion of neutrophil in human umbilical vein endothelial cells.

Authors:  A K Bhunia; T Arai; G Bulkley; S Chatterjee
Journal:  J Biol Chem       Date:  1998-12-18       Impact factor: 5.157

5.  Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice.

Authors:  Thomas E Sussan; Tirumalai Rangasamy; David J Blake; Deepti Malhotra; Hazim El-Haddad; Djahida Bedja; Melinda S Yates; Ponvijay Kombairaju; Masayuki Yamamoto; Karen T Liby; Michael B Sporn; Kathleen L Gabrielson; Hunter C Champion; Rubin M Tuder; Thomas W Kensler; Shyam Biswal
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-22       Impact factor: 11.205

6.  Myriocin slows the progression of established atherosclerotic lesions in apolipoprotein E gene knockout mice.

Authors:  Elias N Glaros; Woojin S Kim; Carmel M Quinn; Wendy Jessup; Kerry-Anne Rye; Brett Garner
Journal:  J Lipid Res       Date:  2007-10-31       Impact factor: 5.922

7.  Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase.

Authors:  S Takahashi; J Suzuki; M Kohno; K Oida; T Tamai; S Miyabo; T Yamamoto; T Nakai
Journal:  J Biol Chem       Date:  1995-06-30       Impact factor: 5.157

8.  A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease.

Authors:  Kerry Anne McEachern; John Fung; Svetlana Komarnitsky; Craig S Siegel; Wei-Lien Chuang; Elizabeth Hutto; James A Shayman; Gregory A Grabowski; Johannes M F G Aerts; Seng H Cheng; Diane P Copeland; John Marshall
Journal:  Mol Genet Metab       Date:  2007-05-16       Impact factor: 4.797

9.  Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity.

Authors:  Johannes M Aerts; Roelof Ottenhoff; Andrew S Powlson; Aldo Grefhorst; Marco van Eijk; Peter F Dubbelhuis; Jan Aten; Folkert Kuipers; Mireille J Serlie; Tom Wennekes; Jaswinder K Sethi; Stephen O'Rahilly; Hermen S Overkleeft
Journal:  Diabetes       Date:  2007-02-07       Impact factor: 9.461

10.  Disruption of Nrf2, a key inducer of antioxidant defenses, attenuates ApoE-mediated atherosclerosis in mice.

Authors:  Thomas E Sussan; Jonathan Jun; Rajesh Thimmulappa; Djahida Bedja; Maria Antero; Kathleen L Gabrielson; Vsevolod Y Polotsky; Shyam Biswal
Journal:  PLoS One       Date:  2008-11-21       Impact factor: 3.240

View more
  51 in total

1.  Aortic perivascular adipose-derived interleukin-6 contributes to arterial stiffness in low-density lipoprotein receptor deficient mice.

Authors:  Bing Du; An Ouyang; Jason S Eng; Bradley S Fleenor
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-04-03       Impact factor: 4.733

2.  A Lipidomics Approach to Assess the Association Between Plasma Sphingolipids and Verbal Memory Performance in Coronary Artery Disease Patients Undertaking Cardiac Rehabilitation: A C18:0 Signature for Cognitive Response to Exercise.

Authors:  Mahwesh Saleem; Nathan Herrmann; Adam Dinoff; Michelle M Mielke; Paul I Oh; Prathiba Shammi; Xingshan Cao; Swarajya Lakshmi Vattem Venkata; Norman J Haughey; Krista L Lanctôt
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

3.  Cardiovascular Imaging in Mice.

Authors:  Colin K L Phoon; Daniel H Turnbull
Journal:  Curr Protoc Mouse Biol       Date:  2016-03-01

4.  MicroRNA-1907 enhances atherosclerosis-associated endothelial cell apoptosis by suppressing Bcl-2.

Authors:  Jin Zhao; Shu-Lin Ou; Wei-You Wang; Chang Yan; Lu-Xiang Chi
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

5.  Astrocyte-derived lactosylceramide implicated in multiple sclerosis.

Authors:  Abdolmohamad Rostami; Bogoljub Ciric
Journal:  Nat Med       Date:  2014-10       Impact factor: 53.440

6.  Untargeted metabolomics identifies a plasma sphingolipid-related signature associated with lifestyle intervention in prepubertal children with obesity.

Authors:  M J Leal-Witt; M Ramon-Krauel; S Samino; M Llobet; D Cuadras; J C Jimenez-Chillaron; O Yanes; C Lerin
Journal:  Int J Obes (Lond)       Date:  2017-08-17       Impact factor: 5.095

7.  Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41.

Authors:  Niranjana Natarajan; Daijiro Hori; Sheila Flavahan; Jochen Steppan; Nicholas A Flavahan; Dan E Berkowitz; Jennifer L Pluznick
Journal:  Physiol Genomics       Date:  2016-09-23       Impact factor: 3.107

8.  Prevention of cardiac hypertrophy by the use of a glycosphingolipid synthesis inhibitor in ApoE-/- mice.

Authors:  Sumita Mishra; Djahida Bedja; Christine Amuzie; Alberto Avolio; Subroto Chatterjee
Journal:  Biochem Biophys Res Commun       Date:  2015-08-04       Impact factor: 3.575

9.  Aging and chronic high-fat feeding negatively affect kidney size, function, and gene expression in CTRP1-deficient mice.

Authors:  Susana Rodriguez; Hannah C Little; Parnaz Daneshpajouhnejad; Paride Fenaroli; Stefanie Y Tan; Dylan C Sarver; Michael Delannoy; C Conover Talbot; Sandeep Jandu; Dan E Berkowitz; Jennifer L Pluznick; Avi Z Rosenberg; G William Wong
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-10-21       Impact factor: 3.619

10.  MiR-129-5p-mediated Beclin-1 suppression inhibits endothelial cell autophagy in atherosclerosis.

Authors:  Zhaohua Geng; Fei Xu; Yiguan Zhang
Journal:  Am J Transl Res       Date:  2016-04-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.